caffeine has been researched along with Pneumonia, Viral in 1 studies
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Having the potential role in suppressing inflammation, immune modulation, antiviral and improving respiratory symptoms, this review discusses the potential role of methylxanthine drugs like pentoxifylline and caffeine in the management of COVID-19 patients." | 5.05 | Can pentoxifylline and similar xanthine derivatives find a niche in COVID-19 therapeutic strategies? A ray of hope in the midst of the pandemic. ( Al-Mahmood Siddiquee, A; Hashemian, F; Monji, F, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Monji, F | 1 |
| Al-Mahmood Siddiquee, A | 1 |
| Hashemian, F | 1 |
1 review available for caffeine and Pneumonia, Viral
| Article | Year |
|---|---|
Can pentoxifylline and similar xanthine derivatives find a niche in COVID-19 therapeutic strategies? A ray of hope in the midst of the pandemic.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Coronavirus Infections; COVID-19; COVID-19 Drug T | 2020 |